Ethema Health Corporation

GRSTOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$772628

P/E Ratio—

52W High$0.0007

52W Low$0.0001

Avg Volume208K

Open$0.00

Beta0.68

Overview

Ethema Health Corporation (GRST) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

GRST · free cash flow · updated Jun 15, 2026

Core FCF metrics

GRST · FCF · TTM · margin & CAGR

Free cash flow was −$755,963 for FY2024 (fiscal year ending 2024-12-31), down 32.4% year-over-year The FCF margin was -12.6%.

FY2024 Free Cash Flow−$755,963▼ -32.4% YoY

Trailing 12M (TTM)−$790,338trailing 4 quarters sum

FCF Margin-12.6%−$755,963 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

GRST · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest−$455,704(0M)−$755,963▼ 32.4%-12.6%

FY2023−$530,157(0M)−$570,759▼ 145.3%-10.7%

FY2022$1.6M(0M)$1.3M▲ +677.5%26.2%

FY2021−$85,567(0M)−$218,399▼ 114.2%-11.2%

FY2020−$101,970(0M)−$101,970▲ +96.6%-30.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

GRST · P/FCF · FCF yield · FCF per share

Ethema Health Corporation (GRST) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

GRST · cash flow statement · operating / investing / financing

For FY2024, Ethema Health Corporation generated −$0.5M in operating cash flow and spent 0M in capital expenditures, yielding −$0.8M in free cash flow.

Operating Activities

−$0.5M

Cash from core business operations

2024-12-31

Investing Activities

−$1.0M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

+$1.7M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF (−$0.5M) − |CapEx| (0M) = FCF (−$0.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

GRST vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Ethema Health CorporationYOU

GRST

−$755,963-32.4%-12.6%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Ethema Health Corporation (GRST) reported free cash flow of −$755,963 for FY2024 (fiscal year ending 2024-12-31), down 32.4% year-over-year. The FCF margin was -12.6%.

Based on available data, Ethema Health Corporation has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $1.3M in FY2022.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

GRST free cash flow · 8 questions

Ethema Health Corporation free cash flow was −$755,963 for FY2024, down 32.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$790,338.

GRST free cash flowGRST FCFGRST FCF 2024GRST free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Ethema Health Corporation · Ethema Health Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026